4.56 USD
-0.07 (-1.51%)
Last: Feb 2, 2026, 08:20 PM
ChartMill assigns a Buy % Consensus number of 82% to LSTA. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 13.26. This target is 190.79% above the current price.
- LSTA was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about LSTA.
- In the previous month the buy percentage consensus was at a similar level.
- LSTA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-21 | Brookline Capital | Downgrade | Buy -> Hold |
| 2025-08-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-15 | Brookline Capital | Maintains | Buy -> Buy |
| 2024-12-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-31 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-10-19 | HC Wainwright & Co. | Maintains | Buy |
LISATA THERAPEUTICS INC / LSTA FAQ
What is the average price target for LISATA THERAPEUTICS INC (LSTA) stock?
9 analysts have analysed LSTA and the average price target is 13.26 USD. This implies a price increase of 190.79% is expected in the next year compared to the current price of 4.56.
What is the consensus rating for LSTA stock?
The consensus rating for LISATA THERAPEUTICS INC (LSTA) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.